BIO.News Newsletter

India’s heatwave is “scorching” wheat crops—highlighting the need for genetically modified wheat. And it’s National Women’s Health Week—a good time to look at the dismal state of maternal mortality in the U.S. and what patient advocacy groups are doing about it. (618 words, 3 minutes, 5 seconds)

We meet the 2022 World Food Prize Laureate, and take a deep dive into the FDA’s new draft guidance on non-opioid analgesics and BIO’s response. (642 words, 3 minutes, 12 seconds)

Ending the week with a recap of yesterday’s Senate subcommittee hearing on pharmacy benefit managers (PBMs) and California’s renewable energy milestone. (606 words, 3 minutes, 1 second)

House Energy & Commerce released a bipartisan package to reauthorize the Prescription Drug User Fee Act (PDUFA) and other user fee agreements—here’s what we know. Plus, we have news about how biotech is improving the tomato and other essential ingredients for Cinco de Mayo. (648 words, 3 minutes, 14 seconds)

Iowa passed a bill to increase availability of E15, a critical component of increasing our energy independence and addressing climate change. And it’s Tardive Dyskinesia Awareness Week—we explain what it is and why knowledge and R&D matter. (570 words, 2 minutes, 51 seconds)

Last week brought positive developments from CMS on reducing patients’ out-of-pocket spending, and BIO’s Dr. Michelle explains why investors should “take a fresh look” at biotech to meet ESG goals. Plus, the new episode of the I am BIO Podcast explores the impact of Alzheimer’s disease—and how biotechnology is offering hope (and possibly a vaccine). (704 words, 3 minutes, 31 seconds)

A new week and a new month, with a look at USTR’s 2022 Special 301 Report (and BIO’s take on it) plus why farmers and investors are looking to biotech to help solve the fertilizer crisis. (685 words, 3 minutes, 25 seconds)

Ending the week with Rep. Barragán’s strong words yesterday about the CMS Aduhelm decision and BeiGene’s news about a state-of-the-art research facility in New Jersey. (524 words, 2 minutes, 37 seconds)

China's proposed human genetic resources regulation may significantly impact global R&D efforts coordinated by foreign entities—here’s why it matters and what BIO’s doing about it. Plus, April is National Minority Health Month and National Limb Loss and Limb Difference Awareness Month—we tell you more about them and the role for biotech. (759 words, 3 minutes, 47 seconds)

Senators questioned FDA officials yesterday—here’s what FDA said about the CMS Aduhelm decision. Also, BIO member BASF opened a new Center for Sustainable Agriculture to highlight biotech innovations. (612 words, 3 minutes, 3 seconds)